Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph A Defronzo

Showing results (31-40 of 313) with videos related to

Pageof 32
Sort By:
Advances in Therapy|June 28, 2018
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled TrialsRalph A DeFronzo, Christopher Lee, Sven Kohler
Current Diabetes Reports|July 16, 2008
Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitusMuhammad A Abdul-Ghani, Ralph A DeFronzo
Current Diabetes Reports|June 4, 2009
Pathophysiology of prediabetesMuhammad A Abdul-Ghani, Ralph A DeFronzo
Expert Opinion on Pharmacotherapy|August 21, 2014
What are the pharmacotherapy options for treating prediabetes?Giuseppe Daniele, Muhammad Abdul-Ghani, Ralph A DeFronzo
Current Opinion in Clinical Nutrition and Metabolic Care|July 9, 2016
Prediabetes and risk of diabetes and associated complications: impaired fasting glucose versus impaired glucose tolerance: does it matter?Muhammad Abdul-Ghani, Ralph A DeFronzo, Amin Jayyousi
Diabetes, Obesity & Metabolism|June 17, 2026
How the First 9 Months Shape the Rest of Your Life: The Impact of Gestational Diabetes on the Metabolic FutureMustafa Kanat, Muhammad Abdul-Ghani, Ralph A DeFronzo
Nature Reviews. Nephrology|December 13, 2016
Renal, metabolic and cardiovascular considerations of SGLT2 inhibitionRalph A DeFronzo, Luke Norton, Muhammad Abdul-Ghani
Diabetes|August 28, 2012
Why Do SGLT2 inhibitors inhibit only 30-50% of renal glucose reabsorption in humans?Jiwen Jim Liu, TaeWeon Lee, Ralph A DeFronzo
Diabetes|October 20, 2020
Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose ToleranceAmalia Gastaldelli, Muhammad Abdul Ghani, Ralph A DeFronzo
Nature Reviews. Nephrology|March 26, 2026
Insulin resistance and hyperinsulinaemia in kidney disease: mechanisms and metabolic effectsHussein Zaitoon, Muhammad Abdul-Ghani, Ralph A DeFronzo
Pageof 32

Showing results (31-40 of 313) with videos related to

Sort By:
Pageof 32
Advances in Therapy|June 28, 2018
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled TrialsRalph A DeFronzo, Christopher Lee, Sven Kohler
Current Diabetes Reports|July 16, 2008
Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitusMuhammad A Abdul-Ghani, Ralph A DeFronzo
Current Diabetes Reports|June 4, 2009
Pathophysiology of prediabetesMuhammad A Abdul-Ghani, Ralph A DeFronzo
Expert Opinion on Pharmacotherapy|August 21, 2014
What are the pharmacotherapy options for treating prediabetes?Giuseppe Daniele, Muhammad Abdul-Ghani, Ralph A DeFronzo
Current Opinion in Clinical Nutrition and Metabolic Care|July 9, 2016
Prediabetes and risk of diabetes and associated complications: impaired fasting glucose versus impaired glucose tolerance: does it matter?Muhammad Abdul-Ghani, Ralph A DeFronzo, Amin Jayyousi
Diabetes, Obesity & Metabolism|June 17, 2026
How the First 9 Months Shape the Rest of Your Life: The Impact of Gestational Diabetes on the Metabolic FutureMustafa Kanat, Muhammad Abdul-Ghani, Ralph A DeFronzo
Nature Reviews. Nephrology|December 13, 2016
Renal, metabolic and cardiovascular considerations of SGLT2 inhibitionRalph A DeFronzo, Luke Norton, Muhammad Abdul-Ghani
Diabetes|August 28, 2012
Why Do SGLT2 inhibitors inhibit only 30-50% of renal glucose reabsorption in humans?Jiwen Jim Liu, TaeWeon Lee, Ralph A DeFronzo
Diabetes|October 20, 2020
Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose ToleranceAmalia Gastaldelli, Muhammad Abdul Ghani, Ralph A DeFronzo
Nature Reviews. Nephrology|March 26, 2026
Insulin resistance and hyperinsulinaemia in kidney disease: mechanisms and metabolic effectsHussein Zaitoon, Muhammad Abdul-Ghani, Ralph A DeFronzo
Pageof 32